DIRS.INFO The most relevant business & tech news

☆ CVS, UnitedHealth, Cigna sue to block FTC case over insulin prices
▼ + stars: | 2024-11-19 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

CVS Health , UnitedHealth Group and Cigna sued the Federal Trade Commission on Tuesday, claiming that the agency's case against drug supply chain middlemen over high insulin prices in the U.S. is unconstitutional. The FTC's in-house administrative process initiates a proceeding before an administrative judge who would hear the case. FTC commissioners then vote on that opinion. The Tuesday complaint argues that the FTC's process violates the companies' due process rights under the Fifth Amendment. The complaint comes a month after CVS, UnitedHealth Group and Cigna demanded FTC Chair Lina Khan and two other commissioners recuse themselves from the agency's in-house suit.

Persons: Cigna, CVS's Caremark, Douglas Farrar, Lina Khan Organizations: CVS Health, UnitedHealth, Federal Trade Commission, Eastern, of, FTC, Cigna's, CVS Locations: U.S, of Missouri, Caremark

☆ RFK Jr. is Trump's pick to lead HHS — here's what he could do with that power
▼ + stars: | 2024-11-19 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +13 min

Kennedy will likely have some influence over who the president-elect chooses for those roles, health policy experts said. Ultimately, Kennedy's influence over immunization policy could lead to an increase in diseases preventable by vaccines, several health policy experts told CNBC. Investors are already bracing for a crackdown on food policy, with shares of processed food companies, such as Pepsi and Coca-Cola , falling on Friday. Seigerman said "there is little precedent in recent history for HHS policy dictating or affecting FDA regulation or approval of drugs." In 2023, pharmaceutical companies spent nearly $3 billion on advertising for the 10 most promoted drugs.

Persons: Robert F, Kennedy Jr, Thomas Machowicz, Donald Trump, Kennedy, Trump, trifecta, Spokespeople, Brandon Guerrero, Christina House, Gostin, Josh Michaud, Lawrence Gostin, Michaud, he's, Genevieve Kanter, Kanter, Covid, Richard Frank, Frank, Evan Seigerman, Seigerman, Dave Latshaw, Latshaw, Drugmakers, Joe Biden's, Amy Campbell Organizations: Reuters, Department of Health, Human Services, Republican, HHS, Affordable, Food and Drug Administration, Centers for Disease Control, National Institutes of Health, Centers, Medicare, Services, CNBC, CVS, Los Angeles Times, Getty, Health Defense, NBC News, FDA, NPR, Georgetown University, CDC, Vaccines, Children, Kennedy, NIH, University of Southern, Brookings Schaeffer Initiative, Health, pharma, RFK, BMO Capital, Pepsi, Trump, University of Illinois Chicago School of Law Locations: Phoenix , Arizona, U.S, Compton, Huntington Park, Kennedy ., University of Southern California

Shares of vaccine makers fell on Thursday as President-elect Donald Trump nominated Robert F. Kennedy Jr., a prominent vaccine skeptic, to lead the Department of Health and Human Services. Moderna’s stock closed more than 5% lower on Thursday, shares of Novavax fell more than 7% and Pfizer’s stock ended more than 2% lower. Shares of BioNTech, the German drugmaker that helped develop a Covid vaccine with Pfizer, closed more than 6% lower. Shares of those companies dipped further in extended trading as Trump confirmed his pick in a post on his platform Truth Social. Kennedy’s track record as a vaccine skeptic is extensive.

Persons: Donald Trump, Robert F, Kennedy Jr, Trump, Kennedy Organizations: Department of Health, Human Services, Pfizer, GSK, Health, Trump, Moderna, Health Defense Locations: Novavax, British, U.S

☆ Amgen stock falls as analysts mull over weight loss drug’s bone density data
▼ + stars: | 2024-11-12 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Shares of Amgen fell more than 7% Tuesday as analysts chewed over bone density loss data from an early-stage trial on its experimental weight loss injection, MariTide. Amgen did not immediately respond to a request for comment on the dataThe drug is a promising potential competitor in the weight loss drug market. "On one hand, patients could naturally lose bone mineral density during weight loss treatment," Brayer wrote. But Brayer said, "on the other hand, this could be a non-starter because there seems to be a dose-dependent increase" in bone mineral density loss. Amgen is also aware of the "hypothetical concern" of bone mineral density loss, Yee said, citing the firm's discussions with management.

Persons: Amgen, Eli Lilly, Cantor Fitzgerald, Olivia Brayer, Eli, Wegovy, Brayer, Jefferies, Michael Yee, Yee, Evan Seigerman, hasn't, Seigerman Organizations: Novo Nordisk, BMO

☆ Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold
▼ + stars: | 2024-11-07 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +5 min

Moderna on Thursday posted a surprise profit for the third quarter, smashing Wall Street estimates, as its cost-cutting efforts took hold and sales of its Covid vaccine came in higher than expected. Before year end, the company plans to file for approval of its experimental "next-generation" Covid vaccine and combination shot targeting Covid and the flu. Moderna this year also expects to apply for expanded approval of its RSV vaccine, targeting high-risk adults ages 18 to 59. "I think the earlier launch and a steeper ramp drove a much higher sales number" for the Covid vaccine, Moderna CEO Stéphane Bancel said in an interview. Analysts had expected sales of $132 million for the RSV vaccine, according to estimates compiled by StreetAccount.

Persons: Moderna, Stéphane Bancel, Bancel, StreetAccount, mull Organizations: Moderna, LSEG, Merck, Research Locations: U.S, Union, Norway, Iceland, Qatar, Europe

☆ How Trump's victory could change abortion rights in America
▼ + stars: | 2024-11-07 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Voters in seven out of 10 states approved ballot measures this week to safeguard abortion rights, a hot-button issue that helped drive Americans to the polls. Trump has waffled considerably on his position on abortion, most recently saying he would not support a federal ban and wants to leave the issue up to the states. "The more restrictions we see on abortion over the next four years, the worse health outcomes are going to be. People are suffering and dying unnecessarily," said Katie O'Connor, senior director of federal abortion policy at the National Women's Law Center. At least 70% of Americans oppose a federal ban on abortion or a ban on the procedure at six weeks.

Persons: Donald Trump, Donald Trump's, Trump, Katie O'Connor, Roe, Wade, O'Connor Organizations: Washington , D.C, National Women's Law, PBS, Associated Press, NORC, for Public Affairs Research, Guttmacher Institute Locations: Washington ,, U.S, telehealth

☆ FDA proposes ending use of decongestant found in many cold, allergy medicines
▼ + stars: | 2024-11-07 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

The Food and Drug Administration on Thursday proposed ending the use of a common ingredient found in many popular over-the-counter cold and allergy medications. The agency said an extensive review of available data determined that the ingredient, oral phenylephrine, doesn't actually relieve nasal congestion. The FDA said the proposed order is not based on safety concerns and not final yet, which means companies can still market over-the-counter drugs containing oral phenylephrine for now. Last year, CVS said it has already moved to pull certain medicines containing oral phenylephrine. The designation, typically used for older medicines, allows drugmakers to include an ingredient in over-the-counter products without the need to file an FDA application.

Persons: doesn't, Patrizia Cavazzoni, Johnson, Kenvue, Phenylephrine, Pseudoephedrine Organizations: Drug Administration, FDA, FDA's Center, Drug, Research, CVS, Procter, Gamble, Bayer, Walgreens, University of Florida, Consumer Healthcare Products Association Locations: Hawthorne , California, U.S

Trump defeated Democratic candidate Vice President Kamala Harris, and Republicans claimed a majority of the Senate in elections this week. "We know kind of where the world is headed in a Trump environment because we've seen it before," said Jeffrey Solomon, president of TD Cowen, on CNBC's "Money Movers" Wednesday. One M&A advisor, who also spoke to CNBC anonymously, noted that Trump's disdain for Big Tech companies — historically active deal-makers — might keep them on the sidelines. Apparent GOP opposition to the CHIPS Act means that semiconductor consolidation might be challenging, the advisor noted, while cautioning it is still too early to know what a Trump presidency would mean. That advisor noted that smaller banks had been getting gobbled up for "some time," but that the pace and size of those acquisitions would likely ramp up under a Trump presidency.

Persons: Donald Trum, Ronda Churchill, Donald Trump, Kamala Harris, Jeffrey Solomon, TD Cowen, Solomon, Trump, Lina Khan, Khan, Howard Gutman, Jonathan Miller, —, Jared Holz, Mizuho, Sen, Elizabeth Warren, David Zaslav, David Grogan Organizations: Republican, Nevada GOP, Afp, Getty, Trump, Democratic, Republicans, Biden administration's Department of Justice, Federal Trade Commission, CNBC, Dow Jones, MorganFranklin Consulting, Big Tech, Qualcomm, Intel, Integrated Media, Pharmaceutical, Biotech, Illumina, FTC, Maze Therapeutics, Sanofi, Senate, DOJ, Allen & Company Sun Valley Conference Locations: Florida, Nevada, Las Vegas , Nevada, Ronda, Trump, Sun Valley , Idaho

☆ CVS posts mixed results, holds off on guidance in Joyner's first earnings report as CEO
▼ + stars: | 2024-11-06 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

CVS Health on Wednesday reported mixed third-quarter results as higher medical costs squeezed its bottom line. The earnings report is CEO David Joyner's first at the helm of the troubled retail drugstore chain. CVS will provide commentary on what it expects "directionally" during its earnings call, the spokesperson said. "Establishing credibility and earning the trust of our investors is one of my top priorities as the new leader of CVS Health," Joyner said in a statement. CVS expects those premium deficiency reserves "to be substantially released" during the fourth quarter, which will benefit results in that period.

Persons: David Joyner's, Joyner, " Joyner, Steve Nelson, Nelson, Prem Shah, Karen Lynch Organizations: CVS Health, CNBC, CVS, Aetna, UnitedHealth, LSEG

☆ Novo Nordisk quarterly profit meets expectations as Wegovy maker narrows full-year guidance
▼ + stars: | 2024-11-06 | by ( Sophie Kiderlin | In | ) www.cnbc.com time to read: +3 min

Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations and narrowed its 2024 full-year growth guidance. The Danish pharmaceutical giant said that its net profit in the third quarter hit 27.3 billion Danish kroner ($3.92 billion), above an LSEG aggregate estimate of 26.95 billion Danish kroner. EBIT — earnings before tax and income — came to 33.8 billion Danish kroner, also just above the LSEG forecast of 33.51 billion Danish kroner. The guidance reflected the company's expectations for sales growth in North America and internationally, which is largely driven by volume growth of treatments based on Glucagon-like peptide-1 (GLP-1), Novo Nordisk said. Novo Nordisk added that it was investing in capacity both internally and externally to increase supply in the short- and long-term.

Persons: —, — CNBC's Annika Kim Constantino Organizations: Novo Nordisk, Wednesday, Novo, Nordisk, U.S . Food, Drug Administration Locations: Danish, North America, Novo, U.S

☆ Trump says he will give RFK Jr. a major health role if he wins the White House. Here's what that means for patients, drugmakers
▼ + stars: | 2024-11-05 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +10 min

Some health experts said elevating Kennedy, even in an informal Trump administration position, could potentially lead to severe consequences for patients, drugmakers and the nation's public health overall. That could exacerbate the nation's existing public health challenges, such as declining childhood vaccination rates for several preventable diseases, some experts say. "I think we could reasonably predict that there would be a decline in vaccination rates among children, and perhaps vaccination overall." Drugmakers such as Pfizer and Moderna are still recovering from falling Covid vaccination rates in the U.S., which have dented their profits over the last two years. Kennedy's other proposals for overhauling federal health agencies will likely be difficult to execute.

Persons: Donald Trump, Robert F, Kennedy Jr, Anna Moneymaker, Kennedy, Trump, Dr, Paul Offit, Drew Altman, Altman, Genevieve Kanter, Cynthia Blancas, Deep Patel, Christina House, they've, Offit, Andrew Kelly, USC's Kanter, that's, Georges Benjamin, Covid, Kanter Organizations: Gas, Getty, White House, Trump, Children's Hospital of Philadelphia, CNBC, and Drug Administration, Centers for Disease Control, Commonwealth Fund, Senate, Washington Post, University of Southern, CVS, Los Angeles Times, CDC, Pfizer, Moderna, NBC, Health Defense, FDA, Department of Health, Human Services, U.S . Food, Drug Administration, Reuters, American Public Health Association, Pharma Locations: Duluth , Georgia, U.S, University of Southern California, Lynwood, Huntington Park, Samoa, White Oak , Maryland

☆ Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
▼ + stars: | 2024-10-31 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023. Bristol Myers Squibb on Thursday reported third-quarter earnings and revenue that blew past Wall Street's expectations thanks to its blockbuster blood thinner Eliquis and a portfolio of drugs it expects to deliver long-term growth. Bristol Myers previously said it expected sales to rise in the "upper end" of the low single-digit range. The results come as Bristol Myers moves to cut $1.5 billion in costs by 2025 and funnel that money into key drug brands and research and development programs. Notably, the Food and Drug Administration approved Bristol Myers Squibb's highly anticipated schizophrenia drug Cobenfy during the quarter.

Persons: Bristol Myers, Joe Biden's, Bristol Myers Squibb's Organizations: Bristol Myers Squibb, LSEG, Food and Drug Administration, Bristol Locations: Cambridge, Cambridge , Massachusetts, Eliquis

☆ Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
▼ + stars: | 2024-10-31 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

Merck on Thursday reported third-quarter revenue and adjusted earnings that topped expectations as the company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business. But Merck's vaccine that prevents cancer from HPV, the most common sexually transmitted infection in the U.S., posted another quarter of lighter-than-expected sales. Revenue from the shot, Gardasil, fell 11% compared to the year-earlier period, mainly due to lower demand in China. The company booked $16.66 billion in revenue for the third quarter, up 4% from the same period a year ago. The loss of exclusive rights to the medicine will likely cause sales to fall, forcing the company to draw revenue from elsewhere.

Persons: Keytruda, Curon, Merck Organizations: Merck, LSEG Locations: Rahway , New Jersey, U.S, China

☆ CDC says 90 people affected in E. coli outbreak linked to McDonald’s Quarter Pounders
▼ + stars: | 2024-10-30 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

Ninety people in 13 states have been infected in a deadly E. coli outbreak linked to McDonald's Quarter Pounders, the Centers for Disease Control and Prevention said Wednesday, as it continues to investigate the source of the spread. Before Wednesday, the CDC last gave an update on the outbreak on Friday, when the agency said it had 75 cases in 13 states. Fresh slivered onions served on Quarter Pounders and other menu items at McDonald's are "the likely source of this outbreak," the CDC said on its website on Wednesday. The CDC believes the risk to the public is "very low" due to the efforts from McDonald's and Taylor Farms. Quarter Pounder hamburgers are a core menu item for McDonald's, raking in billions of dollars each year.

Organizations: Centers for Disease Control, Prevention, CDC, U.S Locations: Colorado, McDonald's, Colorado , Kansas, Wyoming, Idaho , Iowa , Missouri, Montana , Nebraska , Nevada , New Mexico , Oklahoma, Utah

☆ Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
▼ + stars: | 2024-10-30 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Biogen on Wednesday reported third-quarter revenue and adjusted earnings that topped expectations while raising its full-year profit guidance, as sales of its breakthrough Alzheimer's drug, Leqembi, and other new products gain traction. Leqembi, which Biogen shares with the Japanese drugmaker Eisai, became the second drug proven to slow the progression of Alzheimer's to win approval in the U.S. last summer. The drug posted just $10 million in sales last year following its launch. That compares with a net loss of $68.1 million, or 47 cents per share, for the same period a year ago.

Persons: Biogen, StreetAccount Organizations: U.S, Wall Street, LSEG Locations: U.S

☆ Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance
▼ + stars: | 2024-10-30 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

Eli Lilly on Wednesday fell short of profit and revenue expectations for the third quarter, weighed down by disappointing sales of its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro, and slashed its full-year adjusted profit guidance. Eli Lilly now expects full-year adjusted earnings of between $13.02 and $13.52 per share, down from previous guidance of $16.10 to $16.60 per share. Eli Lilly also lowered the high-end of its revenue outlook for the year and now expects sales of between $45.4 billion and $46 billion. The weekly injection raked in $1.26 billion in sales for the period, below the $1.76 billion that analysts expected, according to StreetAccount. As of Wednesday, the Food and Drug Administration's drug database said all doses of Zepbound and Mounjaro are available in the U.S. after extended shortages.

Persons: Eli Lilly, Mounjaro, Eli Lilly's Organizations: Novo Nordisk, LSEG, Food Locations: U.S

☆ Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
▼ + stars: | 2024-10-30 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

Packages containing syringes of the medications Wegovy, Ozempic and Mounjaro at a shop in Mitte, Germany, July 11, 2024. Several doses of semaglutide, the active ingredient in Wegovy and Ozempic, have been on the FDA's shortage list since early 2022. In a statement, Novo Nordisk said all doses of Wegovy and Ozempic are being shipped regularly to wholesalers. Still, Novo Nordisk said patients may not always be able to immediately fill their prescriptions at a particular pharmacy, even when a medication is listed as available. "Our intentional approach to gradually increase supply into the U.S. market is working," Novo Nordisk said.

Persons: Danish drugmaker, Eli Lilly, compounders Organizations: Novo Nordisk, U.S . Food, Nordisk, FDA Locations: Mitte, Germany, U.S, Danish, Novo

☆ Eli Lilly's Zepbound and Mounjaro are no longer in shortage. Here's where their sales still disappointed
▼ + stars: | 2024-10-30 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024. During an earnings call Wednesday, Eli Lilly instead blamed it on drug wholesalers cutting inventory of Zepbound and Mounjaro. On the earnings call, Eli Lilly executives insisted that underlying demand for the medicines remained strong. No," Eli Lilly CEO Dave Ricks said, pointing instead to "a lot of lumpiness in channel stocking." Ricks said Eli Lilly had yet to begin what the company calls "demand-stimulating activities," or advertising and promoting, for Zepbound.

Persons: Eli Lilly, Mounjaro, StreetAccount ., Geoff Meacham, Jared Holz, Mizuho, Carter Gould, Eli Lilly's, tirzepatide, Dave Ricks, Ricks, Lilly Organizations: U.S, StreetAccount, Citi, Barclays, Food and Drug, FDA Locations: Brooklyn, New York, Lilly

☆ Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
▼ + stars: | 2024-10-29 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

Pfizer on Tuesday reported third-quarter revenue and adjusted profit that blew past expectations as the company's Covid vaccine and antiviral pill Paxlovid helped boost sales. Pfizer now expects revenue in a range of $61 billion to $64 billion, up from a previous revenue forecast of between $59.5 billion to $62.5 billion. That includes roughly $5 billion in expected revenue from its Covid vaccine and $5.5 billion from Paxlovid. Pfizer reported revenue of $17.7 billion for the third quarter, up 31% from the same period a year ago. Notably during the quarter, Pfizer withdrew from world markets a critical sickle cell drug it had acquired in a $5.4 billion deal for Global Blood Therapeutics.

Persons: Jeff Smith, Smith, Paxlovid, StreetAccount, Covid Organizations: Pfizer, LSEG, Global Blood Therapeutics Locations: U.S

A deadly E. coli outbreak linked to McDonald 's Quarter Pounders has led to 75 cases in 13 states, the Centers for Disease Control and Prevention said Friday, as it investigates the source of the spread. All of the 42 people who were interviewed by the CDC reported eating at McDonald's, while 39 people reported eating a beef hamburger, the agency said. Quarter Pounder hamburgers are a core menu item for McDonald's, raking in billions of dollars annually. As the CDC and other federal agencies trace cases and work to contain the outbreak, McDonald's has pulled Quarter Pounders from restaurants in the affected areas. Experts told CNBC that barring a more serious crisis, the damage to its brand may be minimal, as with an E. coli outbreak linked to Wendy's two years ago.

Persons: McDonald, McDonald's, Burger, Taco Bell, McDonald's spokespeople, Price Organizations: Centers for Disease Control, Prevention, CDC, Health, KFC, Taco, McDonald's, Wall Street, CNBC Locations: Colorado, McDonald's, Colorado , Kansas , Utah , Wyoming, Idaho , Iowa , Missouri, Montana , Nebraska , Nevada , New Mexico, Oklahoma, California, McDonald's U.S

One of the patients in the McDonald's outbreak suffered from that condition, known as hemolytic uremic syndrome. Hedberg is also a member of the McDonald's Food Safety Advisory Council, but said he has not worked with the company on its response to the outbreak. The size of the outbreak "would imply widespread undercooking by many different individual McDonald's restaurants" if beef was the culprit, according to Hedberg. For example, rival Wendy's dealt with its own link to an E. coli outbreak two years ago. However, that transparency means more media coverage, which reminds consumers about the crisis and risks scaring them away from McDonald's restaurants.

Persons: Michael M, Taylor, it's, spokespeople, McDonald's, Thomas Jaenisch, There's, Xiang Yang, Yang, Craig Hedberg, Hedberg, Jaenisch, Wendy's, Eric Gonzalez, Jack, Chipotle, Gonzalez, Joe Erlinger, Erlinger, Jo, Ellen Pozner, Darin Detwiler, Detwiler, Bill Marler, Marler, Clarissa DeBock, Eric Stelly Organizations: Santiago, Getty, for Disease Control, Taylor, Foods, . Foods, McDonald's, CDC, Colorado School of Public Health, University of California, Food Safety Center of Excellence, Food Safety Advisory, Food and Drug Administration, U.S . Department of Agriculture's, Inspection Service, CNBC, Media, USA, Santa Clara University Leavey School of Business, Northeastern University Locations: Flatbush, Brooklyn, New York City, California, Davis, Colorado, U.S, Minnesota, McDonald's U.S, Nebraska, Greeley , Colorado

☆ Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
▼ + stars: | 2024-10-24 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

Novo Nordisk 's blockbuster diabetes drug Ozempic may reduce the risk of developing Alzheimer's disease, suggesting its potential to delay or prevent the memory-robbing condition, according to a study released Thursday. Alzheimer's disease is often diagnosed in the mild dementia stage, when a person has significant trouble with memory and thinking. But the number of Alzheimer's patients is projected to rise to almost 13 million in the U.S. by 2050. Novo Nordisk, which did not fund the new Case Western study, is also examining semaglutide in a late-stage study on Alzheimer's patients. In the liraglutide research, data from a midstage trial found that the drug may slow the progression of Alzheimer's disease by protecting patients' brains.

Persons: Semaglutide, Dr, Rong Xu, it's, Xu, Eli Lilly, Wegovy, Eli Lilly's Organizations: Novo Nordisk, Alzheimer's Association, Case Western Reserve University, CNBC, Nordisk, Case, National Institutes of Health, GLP Locations: U.S, Novo

☆ Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
▼ + stars: | 2024-10-23 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +4 min

Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. The FDA still has to make a final decision on whether to bar compounded versions of semaglutide, the active ingredient in Ozempic and Wegovy. In a statement, the agency said it is reviewing the petition and will respond directly to Novo Nordisk. The active ingredient in Wegovy and Ozempic, semaglutide, has been in intermittent shortages over the past two years. Like Novo Nordisk, Eli Lilly has sued several weight loss clinics, medical spas and compounding pharmacies across the U.S. over the past year.

Persons: Wegovy, Danish drugmaker, semaglutide, Eli Lilly, Eli Lilly's, compounders Organizations: Novo Nordisk, Tuesday, Food and Drug Administration, FDA, Nordisk Locations: Novo, Danish, U.S

Walmart will start to deliver prescriptions to customers' doorsteps. As CVS and Walgreens shutter hundreds of stores nationwide to shore up profits and investor sentiment, Walmart said Tuesday that it is offering a new option for customers: delivering prescriptions to their doorsteps. The prescription delivery service is another example of how Walmart is trying to outmatch competitors on convenience along with low prices. Still, it is unclear how much market share Walmart could win from CVS and Walgreens, both of which offer same-day, one-day and two-day prescription deliveries. Walmart's delivery service will be available for new prescriptions and refills, the company said.

Persons: Tom Ward, Ward, – Organizations: Walmart, CVS, Walgreens, Walmart U.S, Health Locations: Arkansas , Missouri, New York , Nevada, South Carolina, Wisconsin, North Dakota, U.S

McDonald's shares dropped in premarket trading Wednesday morning after the Centers for Disease Control and Prevention said an E. coli outbreak linked to McDonald's Quarter Pounder burgers has led to 10 hospitalizations and one death. "Most" sick people reported eating a McDonald's Quarter Pounder, the CDC added. McDonald's shares dropped about 7% in trading before the market opened Wednesday. In a statement Tuesday, McDonald's said it is taking "swift and decisive action" following the E. Coli outbreak in certain states. McDonald's has instructed all local restaurants to remove slivered onions from their supply and has paused the distribution of that ingredient in the affected area.

Persons: McDonald's Organizations: Centers for Disease Control, Prevention, CDC Locations: Colorado and Nebraska, Colorado

Search resuls for: "Annika Kim Constantino"

25 mentions found